Business Description
Avalon Globocare Corp
NAICS : 531390
SIC : 6512
ISIN : US05344R1041
Description
Avalon Globocare Corp is an intelligent biotech developer and healthcare service provider dedicated to promoting and empowering high-impact, transformative biotechnology, clinical applications, and healthcare facility management. The company has two reportable segments: the real property operating segment which is the key revenue driver; medical-related consulting services segment. It focuses on diagnostic and therapeutic areas like early detection of oral cancer, ovarian cancer, kidney cancer, skin regeneration and anti-fibrosis, and treatments of degenerative disorders.
Financial Strength
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.03 | |||||
| Equity-to-Asset | 0.36 | |||||
| Debt-to-Equity | 1.15 | |||||
| Debt-to-EBITDA | -0.58 | |||||
| Piotroski F-Score | 3/9 | |||||
| Altman Z-Score | -7.97 | |||||
| Beneish M-Score | -2.32 | |||||
| WACC vs ROIC | ||||||
Growth Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -11.7 | |||||
| 3-Year EBITDA Growth Rate | 2.2 | |||||
| 3-Year EPS without NRI Growth Rate | -0.6 | |||||
| 3-Year FCF Growth Rate | 13.2 |
Momentum Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 32.07 | |||||
| 9-Day RSI | 38.45 | |||||
| 14-Day RSI | 40.31 | |||||
| 6-1 Month Momentum % | -56.86 | |||||
| 12-1 Month Momentum % | -84.63 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.13 | |||||
| Quick Ratio | 0.13 | |||||
| Cash Ratio | 0.04 | |||||
| Days Sales Outstanding | 41.82 | |||||
| Days Payable | 29.1 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -10.2 | |||||
| Shareholder Yield % | -111.89 |
Profitability Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 19.04 | |||||
| Operating Margin % | -572.27 | |||||
| Net Margin % | -1304.14 | |||||
| FCF Margin % | -520.08 | |||||
| ROE % | -111.47 | |||||
| ROA % | -62.07 | |||||
| ROIC % | -27.6 | |||||
| ROC (Joel Greenblatt) % | -6389.79 | |||||
| ROCE % | -72.42 | |||||
| Years of Profitability over Past 10-Year | 1 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 2.14 | |||||
| EV-to-EBIT | -2.09 | |||||
| EV-to-EBITDA | -2.14 | |||||
| EV-to-Revenue | 25.02 | |||||
| EV-to-FCF | -4.81 | |||||
| Earnings Yield (Greenblatt) % | -47.85 | |||||
| FCF Yield % | -224.99 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:ALBT
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Avalon Globocare Corp Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 1.255 | ||
| EPS (TTM) ($) | -1.57 | ||
| Beta | -0.13 | ||
| Volatility % | 29.95 | ||
| 14-Day RSI | 40.31 | ||
| 14-Day ATR ($) | 0.0397 | ||
| 20-Day SMA ($) | 0.313495 | ||
| 12-1 Month Momentum % | -84.63 | ||
| 52-Week Range ($) | 0.25 - 2.419 | ||
| Shares Outstanding (Mil) | 11.1 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Avalon Globocare Corp Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Avalon Globocare Corp Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Avalon Globocare Corp Frequently Asked Questions
What is Avalon Globocare Corp(ALBT)'s stock price today?
The current price of ALBT is $0.26. The 52 week high of ALBT is $2.42 and 52 week low is $0.25.
When is next earnings date of Avalon Globocare Corp(ALBT)?
The next earnings date of Avalon Globocare Corp(ALBT) is 2024-05-22 Est..
Does Avalon Globocare Corp(ALBT) pay dividends? If so, how much?
Avalon Globocare Corp(ALBT) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers